Affiliations

NYBA

Australia Biotech

BioMelbourne

Lab To Wall Street

Of Counsel To Firm

Eric Cohen advises on the full range of business transactions, including: mergers and acquisitions; venture and private equity fund work; corporate governance; licensing; joint ventures; and executive compensation.

Eric's clients include venture capital funds, businesses in fashion, apparel and consumer goods fields, as well as entertainment, technology and manufacturing companies.

Eric was a corporate associate with a specialty in licensing at Wachtel & Maysr, LLP and a corporate associate at Kramer, Levin, Naftalis & Frankel. Eric also serves on the board of a not-for-profit dance and theatre company.

Mr. Cohen graduated Magna Cum Laude from the Benjamin N. Cardozo School of Law and received his undergraduate degree from the University of Michigan at Ann Arbor.

See bio of Roger O'Sullivan >

See bio of John Balestriere >
See bio of Seth Kaufman >

  May 28th, 2009:
Arana Therapeutics Board Changes

May 6th, 2009:
Circadian Scientific Advisory Board Chairman, Professor Kari Alitalo, Wins Prestigious Award for Biomedical Research

May 5th, 2009:
Living Cell Technologies Reports Insulin Independence in Two Patients Following Recent Implants of DIABECELL® in Diabetes Clinical Trial

November 3rd:
FDA Accepts Arana's Anti-inflammatory IND

September 4th:
Cytopia Commences Second Phase II Study in Brain Cancer

September 4th:
Pharmaxis Announces Second Pivotal Phase 3 Trial in Cystic Fibrosis Begins

August 6th:
Xenome Strengthens Board with Two New Appointments

August 6th:
Ciba Elects to Cease Industrial Product Evaluations

June 24th:
New Pharmaxis Board Appointment

April 29th:
Benitec secures further rights to HIV Therapeutic

more industry news >
 


osullivanpllc.com  

Disclaimer